COMMIT HIV Trial Nepal
COMMIT HIV Acceptability and Feasibility Trial
Sponsor: Icahn School of Medicine at Mount Sinai, Department of Health Systems Design and Global Health
Listed as NCT04462679, this NA trial focuses on Hiv and remains ongoing. Sponsored by Icahn School of Medicine at Mount Sinai, Department of Health Systems Design and Global Health, it has been updated 6 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Sep 2022 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Oct 2021 — Sep 2022 [monthly]
Recruiting NA
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Aug 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Feb 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Icahn School of Medicine at Mount Sinai, Department of Health Systems Design and Global Health
- Ministry of Health and Population, Nepal
- National Institute of Mental Health (NIMH)
- Nyaya Health Nepal
- Possible
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .